Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xihuang Capsule is an oral traditional Chinese medicine (TCM) formulation used as an adjunctive therapy for various types of cancer. It originated from a classic formula known as Xihuang Wan (Pill) from the Qing dynasty. [2, 9] The capsule form is considered a modern version with potentially better absorption. [9] It is composed of four main ingredients: Calculus bovis (cattle bezoar), Moschus (musk), Myrrh, and Olibanum (frankincense). [2, 4] In TCM theory, its functions are to clear heat, resolve toxicity, reduce swelling, and invigorate blood to dissipate nodules. [4] Modern research and clinical trials are investigating its efficacy in combination with conventional cancer treatments like chemotherapy and immunotherapy. Studies suggest it possesses multiple anti-tumor properties, including inhibiting cancer cell proliferation and angiogenesis, inducing apoptosis, and modulating the tumor immune microenvironment. [2] It is used for various cancers, including breast, liver, lung, and prostate cancer. [1, 2, 18]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xihuang Capsule.